Skip to main content

The 5 Most Interesting Analyst Questions From Veeva Systems’s Q1 Earnings Call

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

VEEV Cover Image

Veeva Systems’ first quarter saw meaningful progress across its core business lines, with management attributing the results to broad-based customer demand and product execution in both R&D and commercial segments. CEO Peter Gassner highlighted the launch of Veeva’s Falcon platform as a key milestone, describing it as a shift toward “agentic labor”—using AI agents to automate specialized industry tasks. Strong service execution and continued innovation in measurement tools like Crossix also contributed, with management noting that market appetite for digital and AI-driven solutions remains robust.

Is now the time to buy VEEV? Find out in our full research report (it’s free for active Edge members).

Veeva Systems (VEEV) Q1 CY2026 Highlights:

  • Revenue: $882.9 million vs analyst estimates of $857.8 million (16.3% year-on-year growth, 2.9% beat)
  • Adjusted EPS: $2.24 vs analyst estimates of $2.14 (4.9% beat)
  • Adjusted Operating Income: $395.4 million vs analyst estimates of $381.5 million (44.8% margin, 3.6% beat)
  • The company lifted its revenue guidance for the full year to $3.64 billion at the midpoint from $3.59 billion, a 1.3% increase
  • Management raised its full-year Adjusted EPS guidance to $9.05 at the midpoint, a 2.3% increase
  • Operating Margin: 30.9%, in line with the same quarter last year
  • Billings: $850 million at quarter end, up 18.4% year on year
  • Market Capitalization: $27.24 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Veeva Systems’s Q1 Earnings Call

  • Joseph Vruwink (Baird) asked about the scope and customer impact of Falcon. CEO Peter Gassner explained Falcon's aim to automate high-volume, regulated industry tasks, emphasizing that agents would operate within Veeva’s existing applications for maximum efficiency.
  • Brian Peterson (Raymond James) inquired about pharma’s adoption of AI versus traditional SaaS. Gassner described the industry’s move toward a "MAAP" (Models, Agents, Applications) architecture, with AI agents performing high-volume tasks while humans focus on higher-value work.
  • Hoi-Fung Wong (Oppenheimer) questioned the conservative full-year guidance for the R&D business. CFO Brian Van Wagener stated that growth is driven by large, early-stage products and that scaling is still in progress, explaining the measured outlook.
  • Ryan MacDonald (Needham & Company) asked about the Ostro acquisition's integration and value proposition. EVP Paul Shawah highlighted Ostro’s importance in compliant, real-time brand engagement, noting it is now a core part of Veeva’s commercial strategy.
  • Stanislav Berenshteyn (Wells Fargo) sought clarification on margin trends and AI's impact on costs. Van Wagener pointed to ongoing investments in services and product development, but said AI’s margin impact is expected to be immaterial this year outside Ostro.

Catalysts in Upcoming Quarters

In future quarters, StockStory analysts will focus on (1) the pace of Falcon and Vault AI adoption among both small and large biopharma clients, (2) measurable progress in integrating Ostro and scaling its brand engagement capabilities, and (3) continued wins and successful migrations in Vault CRM, especially as remaining top customer decisions unfold. Execution on product innovation and evidence of durable demand in digital analytics will also be important indicators.

Veeva Systems currently trades at $167.69, down from $178.72 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

The Best Stocks for High-Quality Investors

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.19
+0.00 (0.00%)
AAPL  290.55
+0.00 (0.00%)
AMD  475.50
-0.00 (-0.00%)
BAC  54.42
+0.00 (0.00%)
GOOG  362.29
+0.00 (0.00%)
META  584.59
+0.00 (0.00%)
MSFT  403.41
+0.00 (0.00%)
NVDA  208.19
+0.00 (0.00%)
ORCL  205.81
+0.00 (0.00%)
TSLA  396.68
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.